Fortified Tregs to fight atherosclerosis
Author:
Open Access
- 21 March 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 117 (9) , 1987-1988
Abstract
This editorial refers to ‘Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression’ by F. Bonacina et al., pp. 2069–2082.Keywords
Funding Information
- National Institutes of Health (HL136275, HL145241)
This publication has 9 references indexed in Scilit:
- Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progressionCardiovascular Research, 2020
- Treg cell-based therapies: challenges and perspectivesNature Reviews Immunology, 2019
- Immunity and Inflammation in AtherosclerosisCirculation Research, 2019
- AtherosclerosisCirculation Research, 2018
- Minimum Information about T Regulatory Cells: A Step toward Reproducibility and StandardizationFrontiers in Immunology, 2018
- CCR5 + T-bet + FoxP3 + Effector CD4 T Cells Drive AtherosclerosisCirculation Research, 2016
- Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient MiceCirculation, 2010
- CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survivalBlood, 2009
- Plasma-derived microparticles for biomarker discovery.2008